Jenny A Prange as co-founder and CSO of MUVON, Jenny is coordinating all research
activities aiming towards the improvement of cell production and the therapy in general and
manages the GMP production. She initially joined the team early in 2017 for the setup of
the GMP-compliant production of muscle precursor as part of the MUSIC project. Jenny obtained
her PhD in Integrative Molecular Medicine from the University of Zurich and gained
research experience during her studies at Roche in Switzerland, Novartis in the US, and
the Federal Research Institute for Animal Health in Germany. Jenny holds a Diplôme d’Ingénieure
in Biotechnology from the Ecole supérieure de Biotechnologie de Strasbourg as
well as a Master’s degree in Biotechnology and Therapeutic Innovation from the University
of Strasbourg.
Beatrix Rauch-Schmid - Innovation Manager - She finished her biotechnology studies
2006 with a diploma thesis in tissue engineering on the regeneration of cartilage at the fzmb
in Germany and broadened her R&D experience at the Australian ANU and many years at
Roche. She finalized her MAS-MTEC Studies (ETH) at the Chair of Innovation. Beatrix joined
MUVON Therapeutics in the beginning of 2021 and is responsible for the coordination of
innovation projects such as automating the production process.
